Hidradenitis Suppurativa Clinical Trials

Active, not recruiting

Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)

NCT06956235

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations: Cahaba Dermatology & Skin Health Center ( Site 0012) Birmingham, Alabama, United States

Medical Dermatology Specialists ( Site 0027) Phoenix, Arizona, United States

Northwest Arkansas Clinical Trials Center, PLLC ( Site 0049) Rogers, Arkansas, United States

Northridge Clinical Trials ( Site 0004) Northridge, California, United States

View all 68 locations

View Trial Details

Active, not recruiting

A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

NCT06468228

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations: Cahaba Dermatology & Skin Health Center /ID# 263795 Birmingham, Alabama, United States

Medical Dermatology Specialists /ID# 263394 Phoenix, Arizona, United States

Banner University Medicine Dermatology /ID# 263557 Tucson, Arizona, United States

Dermatology Trial Associates /ID# 264587 Bryant, Arkansas, United States

View all 279 locations

View Trial Details

Active, not recruiting

A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.

NCT07228390

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations: Medical Dermatology Specialists Phoenix, Arizona, United States

Mayo Clinic Hospital Phoenix, Arizona, United States

Mayo Clinic Specialty Building Phoenix, Arizona, United States

Mayo Clinic Scottsdale, Arizona, United States

View all 67 locations

View Trial Details

Active, not recruiting

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa

NCT06840392

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Dermatitis, +9 more
Locations: Total Skin and Beauty Dermatology Center PC Birmingham, Alabama, United States

CTT Research Gilbert, Arizona, United States

Ctr for Dermatology Clinical Res Fremont, California, United States

USC Keck School of Medicine Los Angeles, California, United States

View all 130 locations

View Trial Details

Active, not recruiting

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)

NCT06799000

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Dermatitis, +9 more
Locations: Medical Dermatology Specialists Phoenix, Arizona, United States

Johnson Dermatology Fort Smith, Arkansas, United States

Arkansas Research Trials North Little Rock, Arkansas, United States

Cheryl Effron MD Inc Anaheim, California, United States

View all 139 locations

View Trial Details

Active, not recruiting

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

NCT05889182

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations: Cahaba Dermatology & Skin Health Center /ID# 254876 Birmingham, Alabama, United States

Peak Dermatology Aesthetics and Wellness Fountain Hills /ID# 272564 Fountain Hills, Arizona, United States

Medical Dermatology Specialists /ID# 254226 Phoenix, Arizona, United States

Mayo Clinic - Scottsdale /ID# 254388 Scottsdale, Arizona, United States

View all 285 locations

View Trial Details

Active, not recruiting

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)

NCT06959225

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations: Investigative Site US020 Phoenix, Arizona, United States

Investigative Site US033 Scottsdale, Arizona, United States

Investigative Site US054 Tempe, Arizona, United States

Investigative Site US002 Fayetteville, Arkansas, United States

View all 101 locations

View Trial Details

Active, not recruiting

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.

NCT05921994

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations: Novartis Investigative Site Freiburg im Breisgau, Baden-Wurttemberg, Germany

Novartis Investigative Site Rheinstetten, Baden-Wurttemberg, Germany

Novartis Investigative Site Haßfurt, Bavaria, Germany

Novartis Investigative Site Kulmbach, Bavaria, Germany

View all 80 locations

View Trial Details

Active, not recruiting

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

NCT06958211

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations: Investigative Site US257 Birmingham, Alabama, United States

Investigative Site US218 Birmingham, Alabama, United States

Investigative Site US239 Montgomery, Alabama, United States

Investigative Site US215 Phoenix, Arizona, United States

View all 107 locations

View Trial Details

Active, not recruiting

Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab.

NCT06785675

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
Locations: Novartis Investigative Site Al Ain Abu Dhabi, United Arab Emirates

Novartis Investigative Site Abu Dhabi, United Arab Emirates

Novartis Investigative Site Ras al-Khaimah, United Arab Emirates

Novartis Investigative Site Sharjah city, United Arab Emirates

View Trial Details

Hidradenitis Suppurativa

Hidradenitis Suppurativa trial results

Related conditions